Samalin Investment Counsel, LLC Organon & Co. Transaction History

Samalin Investment Counsel, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $19,597 - $24,079	-619 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $30 - $39	1 Added 0.16%	619 $21.6 Million
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $2,264 - $2,933	-79 Reduced 11.33%	618 $18.8 Million
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $601 - $748	21 Added 3.11%	697 $22.9 Million
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $19,232 - $25,688	676 New	676 $20,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.